USPTO serial 74599005
SCRIPTGEN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, LAURA E
- Law office
- PETITIONS OFFICE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SCRIPTGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amy J. Benjamin
AMY J BENJAMIN DARBY & DARBY PC805 THIRD AVENEW YORK, NY 10022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment of infectious diseases including, but not limited to bacterial, fungal, and viral infections; peripheral or central nervous system diseases including, but not limited to schizophrenia, depression, alzheimers, migraines, anxiety, and pain; cardiovascular system diseases including, but not limited to atherosclerosis, hypertension, stroke, and congestive heart failure; digestive organs diseases including, but not limited to gastric ulcers, and esophagal reflux; musculosketal system diseases including, but not limited to arthritis; metabolic diseases including, but not limited to obesity and diabetes; respiratory system diseases including, but not limited to asthma, pneumonia, and tuberculosis; urogenital organs diseases including, but not limited to cystitis, yeast infections, and hepatitis; neoplastic diseases including, but not limited to cancer of the breast, lung, prostate, and colon; skin disorders including, but not limited to psoriasis and herpes; immune system diseases including, but not limited to HIV, rheumatoid arthritis, and immune suppression agents for organ transplants; hematopoietic diseases including, but not limited to sickle cell anemia, thalassemia, hemostasis and other blood disorders; genetic diseases including, but not limited to down's syndrome, Huntington's chorea, and cystic fibrosis; endocrine system diseases including, but not limited to symptoms of menopause; reproductive system diseases including, but not limited to fertility control | ACTIVE | — |
| 042 | research services in the field of biology and medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SCRIPTGEN PHARMACEUTICALS, INC.
- Other trademarks owned by SCRIPTECH PHARMACEUTICAL, INC.
- Other trademarks owned by SCRIPTGEN PHARMACEUTICALS, INC.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named SCRIPTGEN
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 21, 2000 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 8, 1999 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Feb 16, 1999 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 22, 1998 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 2, 1998 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 13, 1998 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 3, 1998 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 1, 1997 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 13, 1997 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 2, 1997 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 28, 1997 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 3, 1996 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 11, 1996 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 1996 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 21, 1996 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 1996 | REIN | REINSTATED | — |
| Dec 14, 1995 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 26, 1995 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 1995 | DOCK | ASSIGNED TO EXAMINER | — |